United States Plasma Protein Therapeutics Market by Manufacturers, States, Type and Application, Forecast to 2022

Publisher Name :
Date: 05-Dec-2017
No. of pages: 119

"Plasma Protein Therapeutics is use blood products to treat disease.

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product."

Scope of the Report:

This report focuses on the Plasma Protein Therapeutics in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers

  • Shire (Baxalta)

  • CSL

  • Grifols

  • Octapharma

  • Kedrion

  • LFB Group

  • Biotest

  • BPL

  • RAAS

  • CBPO

  • Hualan Bio

  • Kamada

Market Segment by States, covering

  • California

  • Texas

  • New York

  • Florida

  • Illinois

Market Segment by Type, covers

  • Coagulation Factor

  • Immune Globulin

  • Albumin

  • Other

Market Segment by Applications, can be divided into

  • Hemophilia

  • PID

  • Other

There are 17 Chapters to deeply display the United States Plasma Protein Therapeutics market.

Chapter 1, to describe Plasma Protein Therapeutics Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Plasma Protein Therapeutics, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Plasma Protein Therapeutics, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Plasma Protein Therapeutics market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Plasma Protein Therapeutics Research Findings and Conclusion, Appendix, methodology and data source.

United States Plasma Protein Therapeutics Market by Manufacturers, States, Type and Application, Forecast to 2022

Table of Contents

1 Market Overview
1.1 Plasma Protein Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Coagulation Factor
1.2.2 Immune Globulin
1.2.3 Albumin
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Hemophilia
1.3.2 PID
1.3.3 Other
1.4 Market Analysis by States
1.4.1 California Status and Prospect (2012-2022)
1.4.2 Texas Status and Prospect (2012-2022)
1.4.3 New York Status and Prospect (2012-2022)
1.4.4 Florida Status and Prospect (2012-2022)
1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 Shire (Baxalta)
2.1.1 Profile
2.1.2 Plasma Protein Therapeutics Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Shire (Baxalta) News
2.2 CSL
2.2.1 Profile
2.2.2 Plasma Protein Therapeutics Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 CSL Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 CSL News
2.3 Grifols
2.3.1 Profile
2.3.2 Plasma Protein Therapeutics Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Grifols Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Grifols News
2.4 Octapharma
2.4.1 Profile
2.4.2 Plasma Protein Therapeutics Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Octapharma Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Octapharma News
2.5 Kedrion
2.5.1 Profile
2.5.2 Plasma Protein Therapeutics Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Kedrion Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Kedrion News
2.6 LFB Group
2.6.1 Profile
2.6.2 Plasma Protein Therapeutics Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 LFB Group Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 LFB Group News
2.7 Biotest
2.7.1 Profile
2.7.2 Plasma Protein Therapeutics Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Biotest Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Biotest News
2.8 BPL
2.8.1 Profile
2.8.2 Plasma Protein Therapeutics Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 BPL Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 BPL News
2.9 RAAS
2.9.1 Profile
2.9.2 Plasma Protein Therapeutics Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 RAAS Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 RAAS News
2.10 CBPO
2.10.1 Profile
2.10.2 Plasma Protein Therapeutics Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 CBPO Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 CBPO News
2.11 Hualan Bio
2.11.1 Profile
2.11.2 Plasma Protein Therapeutics Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 Hualan Bio News
2.12 Kamada
2.12.1 Profile
2.12.2 Plasma Protein Therapeutics Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Kamada Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 Kamada News

3 United States Plasma Protein Therapeutics Market Competition, by Manufacturer
3.1 United States Plasma Protein Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Plasma Protein Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Plasma Protein Therapeutics Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Plasma Protein Therapeutics Manufacturer Market Share
3.4.2 Top 5 Plasma Protein Therapeutics Manufacturer Market Share
3.5 Market Competition Trend

4 United States Plasma Protein Therapeutics Market Analysis by States
4.1 United States Plasma Protein Therapeutics Sales Market Share by States
4.2 United States Plasma Protein Therapeutics Sales by States (2012-2017)
4.3 United States Plasma Protein Therapeutics Revenue (Value) by States (2012-2017)

5 United States Market Segmentation Plasma Protein Therapeutics by Type
5.1 United States Plasma Protein Therapeutics Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 United States Plasma Protein Therapeutics Sales and Market Share by Type (2012-2017)
5.1.2 United States Plasma Protein Therapeutics Revenue and Market Share by Type (2012-2017)
5.2 Coagulation Factor Sales Growth and Price
5.2.1 United States Coagulation Factor Sales Growth (2012-2017)
5.2.2 United States Coagulation Factor Price (2012-2017)
5.3 Immune Globulin Sales Growth and Price
5.3.1 United States Immune Globulin Sales Growth (2012-2017)
5.3.2 United States Immune Globulin Price (2012-2017)
5.4 Albumin Sales Growth and Price
5.4.1 United States Albumin Sales Growth (2012-2017)
5.4.2 United States Albumin Price (2012-2017)
5.5 Other Sales Growth and Price
5.5.1 United States Other Sales Growth (2012-2017)
5.5.2 United States Other Price (2012-2017)

6 United States Market Segmentation Plasma Protein Therapeutics by Application
6.1 United States Plasma Protein Therapeutics Sales Market Share by Application (2012-2017)
6.2 Hemophilia Sales Growth (2012-2017)
6.3 PID Sales Growth (2012-2017)
6.4 Other Sales Growth (2012-2017)

7 California Plasma Protein Therapeutics Sales, Revenue, by Type, Application and Manufacturers
7.1 California Plasma Protein Therapeutics Revenue, Sales and Growth Rate (2012-2017)
7.2 California Plasma Protein Therapeutics Sales and Market Share by Type
7.3 California Plasma Protein Therapeutics Sales by Application (2012-2017)

8 New York Plasma Protein Therapeutics Sales, Revenue, by Type, Application and Manufacturers
8.1 New York Plasma Protein Therapeutics Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Plasma Protein Therapeutics Sales and Market Share by Type
8.3 New York Plasma Protein Therapeutics Sales by Application (2012-2017)

9 Texas Plasma Protein Therapeutics Sales, Revenue, by Type, Application and Manufacturers
9.1 Texas Plasma Protein Therapeutics Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Plasma Protein Therapeutics Sales and Market Share by Type
9.3 Texas Plasma Protein Therapeutics Sales by Application (2012-2017)

10 Florida Plasma Protein Therapeutics Sales, Revenue, by Type, Application and Manufacturers
10.1 Florida Plasma Protein Therapeutics Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Plasma Protein Therapeutics Sales and Market Share by Type
10.3 Florida Plasma Protein Therapeutics Sales by Application (2012-2017)

11 Illinois Plasma Protein Therapeutics Sales, Revenue, by Type, Application and Manufacturers
11.1 Illinois Plasma Protein Therapeutics Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Plasma Protein Therapeutics Sales and Market Share by Type
11.3 Illinois Plasma Protein Therapeutics Sales by Application (2012-2017)

12 Plasma Protein Therapeutics Market Forecast (2017-2022)
12.1 United States Plasma Protein Therapeutics Sales, Revenue and Growth Rate (2017-2022)
12.2 Plasma Protein Therapeutics Market Forecast by States (2017-2022)
12.3 Plasma Protein Therapeutics Market Forecast by Type (2017-2022)
12.4 Plasma Protein Therapeutics Market Forecast by Application (2017-2022)

13 Plasma Protein Therapeutics Manufacturing Cost Analysis
13.1 Plasma Protein Therapeutics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Price Trend of Key Raw Materials
13.1.3 Key Suppliers of Raw Materials
13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.2.1 Raw Materials
13.2.2 Labor Cost
13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Plasma Protein Therapeutics

14 Industrial Chain, Sourcing Strategy and Downstream Buyers
14.1 Plasma Protein Therapeutics Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Plasma Protein Therapeutics Major Manufacturers in 2016
14.4 Downstream Buyers

15 Sales Channel, Distributors, Traders and Dealers
15.1 Sales Channel
15.1.1 Direct Marketing
15.1.2 Indirect Marketing
15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source

List of Tables and Figures

Figure Plasma Protein Therapeutics Picture
Table Product Specifications of Plasma Protein Therapeutics
Figure United States Sales Market Share of Plasma Protein Therapeutics by Types in 2016
Table Types of Plasma Protein Therapeutics
Figure Coagulation Factor Picture
Table Major Manufacturers of Coagulation Factor
Figure Immune Globulin Picture
Table Major Manufacturers of Immune Globulin
Figure Albumin Picture
Table Major Manufacturers of Albumin
Figure Other Picture
Table Major Manufacturers of Other
Table United States Plasma Protein Therapeutics Sales Market Share by Applications in 2016
Table Applications of Plasma Protein Therapeutics
Figure Hemophilia Picture
Figure PID Picture
Figure Other Picture
Figure California Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Table Shire (Baxalta) Basic Information, Manufacturing Base and Competitors
Table Shire (Baxalta) Plasma Protein Therapeutics Type and Applications
Table Shire (Baxalta) Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Plasma Protein Therapeutics Type and Applications
Table CSL Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Grifols Basic Information, Manufacturing Base and Competitors
Table Grifols Plasma Protein Therapeutics Type and Applications
Table Grifols Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Octapharma Basic Information, Manufacturing Base and Competitors
Table Octapharma Plasma Protein Therapeutics Type and Applications
Table Octapharma Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kedrion Basic Information, Manufacturing Base and Competitors
Table Kedrion Plasma Protein Therapeutics Type and Applications
Table Kedrion Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table LFB Group Basic Information, Manufacturing Base and Competitors
Table LFB Group Plasma Protein Therapeutics Type and Applications
Table LFB Group Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biotest Basic Information, Manufacturing Base and Competitors
Table Biotest Plasma Protein Therapeutics Type and Applications
Table Biotest Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BPL Basic Information, Manufacturing Base and Competitors
Table BPL Plasma Protein Therapeutics Type and Applications
Table BPL Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table RAAS Basic Information, Manufacturing Base and Competitors
Table RAAS Plasma Protein Therapeutics Type and Applications
Table RAAS Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CBPO Basic Information, Manufacturing Base and Competitors
Table CBPO Plasma Protein Therapeutics Type and Applications
Table CBPO Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hualan Bio Basic Information, Manufacturing Base and Competitors
Table Hualan Bio Plasma Protein Therapeutics Type and Applications
Table Hualan Bio Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kamada Basic Information, Manufacturing Base and Competitors
Table Kamada Plasma Protein Therapeutics Type and Applications
Table Kamada Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Plasma Protein Therapeutics Sales by Manufacturer (2016-2017)
Figure United States Plasma Protein Therapeutics Sales Market Share by Manufacturer in 2016
Figure United States Plasma Protein Therapeutics Sales Market Share by Manufacturer in 2017
Table United States Plasma Protein Therapeutics Revenue by Manufacturer (2016-2017)
Figure United States Plasma Protein Therapeutics Revenue Market Share by Manufacturer in 2015
Figure United States Plasma Protein Therapeutics Revenue Market Share by Manufacturer in 2016
Table United States Plasma Protein Therapeutics Price by Manufacturers (2016-2017)
Figure Top 3 Plasma Protein Therapeutics Manufacturer Market Share in 2016
Figure Top 3 Plasma Protein Therapeutics Manufacturer Market Share in 2017
Figure Top 5 Plasma Protein Therapeutics Manufacturer Market Share in 2016
Figure Top 5 Plasma Protein Therapeutics Manufacturer Market Share in 2017
Figure United States Plasma Protein Therapeutics Sales and Growth (2012-2017)
Table United States Plasma Protein Therapeutics Sales by States (2012-2017)
Table United States Plasma Protein Therapeutics Sales Market Share by States (2012-2017)
Figure United States 2012 Plasma Protein Therapeutics Sales Market Share by States
Figure United States 2016 Plasma Protein Therapeutics Sales Market Share by States
Figure United States Plasma Protein Therapeutics Revenue and Growth (2012-2017)
Table United States Plasma Protein Therapeutics Revenue by States (2012-2017)
Table United States Plasma Protein Therapeutics Revenue Market Share by States (2012-2017)
Table United States 2012 Plasma Protein Therapeutics Revenue Market Share by States
Table United States 2016 Plasma Protein Therapeutics Revenue Market Share by States
Table United States Plasma Protein Therapeutics Sales by Type (2012-2017)
Table United States Plasma Protein Therapeutics Sales Share by Type (2012-2017)
Table United States Plasma Protein Therapeutics Revenue by Type (2012-2017)
Table United States Plasma Protein Therapeutics Revenue Share by Type (2012-2017)
Figure United States Coagulation Factor Sales Growth (2012-2017)
Figure United States Coagulation Factor Price (2012-2017)
Figure United States Immune Globulin Sales Growth (2012-2017)
Figure United States Immune Globulin Price (2012-2017)
Figure United States Albumin Sales Growth (2012-2017)
Figure United States Albumin Price (2012-2017)
Figure United States Other Sales Growth (2012-2017)
Figure United States Other Price (2012-2017)
Table United States Plasma Protein Therapeutics Sales by Application (2012-2017)
Table United States Plasma Protein Therapeutics Sales Share by Application (2012-2017)
Figure United States Hemophilia Sales Growth (2012-2017)
Figure United States PID Sales Growth (2012-2017)
Figure United States Other Sales Growth (2012-2017)
Figure California Plasma Protein Therapeutics Revenue and Growth (2012-2017)
Figure California Plasma Protein Therapeutics Sales and Growth (2012-2017)
Table California Plasma Protein Therapeutics Sales by Type (2012-2017)
Table California Plasma Protein Therapeutics Sales Market Share by Type (2012-2017)
Table California Plasma Protein Therapeutics Sales by Application (2012-2017)
Table California Plasma Protein Therapeutics Sales Market Share by Application (2012-2017)
Figure New York Plasma Protein Therapeutics Revenue and Growth (2012-2017)
Figure New York Plasma Protein Therapeutics Sales and Growth (2012-2017)
Table New York Plasma Protein Therapeutics Sales by Type (2012-2017)
Table New York Plasma Protein Therapeutics Sales Market Share by Type (2012-2017)
Table New York Plasma Protein Therapeutics Sales by Application (2012-2017)
Table New York Plasma Protein Therapeutics Sales Market Share by Application (2012-2017)
Figure Texas Plasma Protein Therapeutics Revenue and Growth (2012-2017)
Figure Texas Plasma Protein Therapeutics Sales and Growth (2012-2017)
Table Texas Plasma Protein Therapeutics Sales by Type (2012-2017)
Table Texas Plasma Protein Therapeutics Sales Market Share by Type (2012-2017)
Table Texas Plasma Protein Therapeutics Sales by Application (2012-2017)
Table Texas Plasma Protein Therapeutics Sales Market Share by Application (2012-2017)
Figure Florida Plasma Protein Therapeutics Revenue and Growth (2012-2017)
Figure Florida Plasma Protein Therapeutics Sales and Growth (2012-2017)
Table Florida Plasma Protein Therapeutics Sales by Type (2012-2017)
Table Florida Plasma Protein Therapeutics Sales Market Share by Type (2012-2017)
Table Florida Plasma Protein Therapeutics Sales by Application (2012-2017)
Table Florida Plasma Protein Therapeutics Sales Market Share by Application (2012-2017)
Figure Illinois Plasma Protein Therapeutics Revenue and Growth (2012-2017)
Figure Illinois Plasma Protein Therapeutics Sales and Growth (2012-2017)
Table Illinois Plasma Protein Therapeutics Sales by Type (2012-2017)
Table Illinois Plasma Protein Therapeutics Sales Market Share by Type (2012-2017)
Table Illinois Plasma Protein Therapeutics Sales by Application (2012-2017)
Table Illinois Plasma Protein Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Plasma Protein Therapeutics Sales, Revenue and Growth Rate (2017-2022)
Table United States Plasma Protein Therapeutics Sales Forecast by States (2017-2022)
Table United States Plasma Protein Therapeutics Market Share Forecast by States (2017-2022)
Table United States Plasma Protein Therapeutics Sales Forecast by Type (2017-2022)
Table United States Plasma Protein Therapeutics Market Share Forecast by Type (2017-2022)
Table United States Plasma Protein Therapeutics Sales Forecast by Application (2017-2022)
Table United States Plasma Protein Therapeutics Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Plasma Protein Therapeutics
Figure Manufacturing Process Analysis of Plasma Protein Therapeutics
Figure Plasma Protein Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Plasma Protein Therapeutics Major Manufacturers in 2016
Table Major Buyers of Plasma Protein Therapeutics
Table Distributors/Traders/ Dealers List
  • Global Calming and Sleeping Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Oct-2018        Price: US 3480 Onwards        Pages: 132
    Calming and sleeping products reduce tension and anxiety by inducing sedatives and a hypnotic effect on the body. They act by depressing the central nervous system. Scope of the Report: This report focuses on the Calming and Sleeping in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. They are used to tr......
  • Global Glycinates Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Oct-2018        Price: US 3480 Onwards        Pages: 137
    Glycine is an amino acid of endogenous antioxidant reductive glutathione. It is often added exogenously in severe stress, sometimes called semi-essential amino acid. Scope of the Report: This report focuses on the Glycinates in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The feed additive segment is ......
  • Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 35
    Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Aurora Kinase C is a member of the Aurora sub......
  • Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 74
    Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) - Pipeline Review, H2 2018 Summary Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) pipeline Target constitutes close to 15 molecules. Out of which app......
  • Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 50
    Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2018 Summary Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Transforming growth factor beta 2 (TGF-ß2) is a polypeptide member of the transforming growth factor beta superfamily of cytokines encoded by......
  • Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 73
    Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2018 Summary Transforming Growth Factor Beta 1 (TGFB1) pipeline Target constitutes close to 22 molecules. Out of which approximately 15 molecules are developed by companies and remaining by the universities/institutes. The latest report Transforming Growth Factor Beta 1- Pipeline Review, H2 2018, outlays comprehensive information on the Transforming Growth Factor Beta 1 (TGFB1) targeted therapeutics, co......
  • Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 69
    Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018 Summary Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Beta-secretase 1 (BACE1) is an enzyme that in humans is encoded by the BACE1 ......
  • Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 73
    Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018 Summary According to the recently published report 'Lysosomal Alpha Glucosidase - Pipeline Review, H2 2018'; Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) pipeline Target constitutes close to 16 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes......
  • Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 56
    Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) pipeline Target constitutes close to 17 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report Glycogen Synthase Kinase 3 Be......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs